MAPT and Alzheimer disease: Although we and other groups have already developed PET probes to visualize mature Tau fibrils (Maruyama et al, 2013), there have been no sensitive readouts for the detection of soluble Tau oligomers that are thought to act as major neurotoxic species in AD (Kopeikina et al, 2012; Takashima, 2013).